/Investor DB

Fulcrum Global Capital — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Resilient Bioticsresilientbiotics.cominDec 2020

Resilient Biotics uses microbiome genomics and data science to discover and develop non-antibiotic, precision microbial therapeutics derived from commensal microbial communities, aimed at preventing respiratory infectious diseases.

AI & Machine LearningBiotechHealthtechResearch Triangle Park, US

Rachelle Galvin(Executive Officer, Director)Christopher Belnap(Executive Officer, Director)Greg Werner(Executive Officer, Director)

BoardDrew Lanza(Director)inEric Eason(Director)

PartnerKevin Lockett· solo GP

Board seatJohn Peryam· per SEC Form D

Co-investorsBerkeley Catalyst

TeleSensetelesense.comin𝕏Jun 2020 · $10.2M

TeleSense provides wireless sensors and data-science software that continuously monitor temperature, humidity, and carbon dioxide in stored grain to detect and prevent spoilage.

AgTechAI & Machine LearningIoTSunnyvale, US

Naeem Zafar(Co-Founder and Advisor)inNick Garner(Co-Founder & Chief Engineer)Ali Ahmed(Chief Technology Officer)Mark Palmquist(Director)Soren Schroder(Director)John Tingleff(Executive Officer)

PartnerKevin Lockett· solo GP

Co-investorsCongruent VenturesMaersk GrowthMindset VentureRabo Corporate VenturingRadicle GrowthArtesian+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Arvegenix

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.